Spatial Biology is an emerging discipline in Europe that has already provided valuable insights into cancer biology and disease processes, offering scientists a deeper understanding of complex phenomena. With the rapid progress of this technology, novel insights in multiple disease areas have been uncovered, leading to the development of improved approaches in therapeutic interventions.

However, the lack of a standardised pathway for spatial imaging, analysis, and data interpretation poses challenges in drug development, accompanied by uncertainties and ongoing legal disputes.

This conference aims to unite industry experts, fostering collaboration and knowledge sharing to overcome these hurdles and fully capitalise on the potential of spatial biology. Join us as we explore practical selection and implementation strategies, and learn from case studies across various disease areas to revolutionise drug development portfolios.